← Evidence map

ArticleBlood neoplasia2026

FLT3 (CD135) expression in pediatric AML is associated with distinct features and worse outcomes with sorafenib therapy.

Andrew J Menssen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42602269